ANI Pharmaceuticals Inc., of Baudette, Minn., said it closed an underwritten public offering of its 3 percent convertible senior notes due 2019 in the aggregate principal amount of $143.75 million, which includes the full exercise of the underwriters’ over-allotment option to purchase $18.75 million of notes.